Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
149,544,182
-
Number of holders
-
97
-
Total 13F shares, excl. options
-
33,888,914
-
Shares change
-
+2,924,432
-
Total reported value, excl. options
-
$739,147,936
-
Value change
-
+$60,802,116
-
Number of buys
-
66
-
Number of sells
-
-20
-
Price
-
$21.81
Significant Holders of Avidity Biosciences, Inc. - Common Stock (RNA) as of Q1 2021
105 filings reported holding RNA - Avidity Biosciences, Inc. - Common Stock as of Q1 2021.
Avidity Biosciences, Inc. - Common Stock (RNA) has 97 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33,888,914 shares
of 149,544,182 outstanding shares and own 22.66% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (3,995,000 shares), FMR LLC (3,433,588 shares), BlackRock Inc. (2,689,727 shares), Cormorant Asset Management, LP (2,464,545 shares), EcoR1 Capital, LLC (2,103,950 shares), FEDERATED HERMES, INC. (1,800,434 shares), PRICE T ROWE ASSOCIATES INC /MD/ (1,757,735 shares), ALETHEA CAPITAL MANAGEMENT, LLC (1,385,864 shares), STATE STREET CORP (1,348,673 shares), and VANGUARD GROUP INC (1,283,071 shares).
This table shows the top 97 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.